BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1398 related articles for article (PubMed ID: 23153532)

  • 41. Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway.
    Ren L; Wang X; Dong Z; Liu J; Zhang S
    Med Oncol; 2013; 30(3):634. PubMed ID: 23813018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis.
    Jenkins BJ; Roberts AW; Greenhill CJ; Najdovska M; Lundgren-May T; Robb L; Grail D; Ernst M
    Blood; 2007 Mar; 109(6):2380-8. PubMed ID: 17082315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
    Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
    Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholest-4-en-3-one attenuates TGF-β responsiveness by inducing TGF-β receptors degradation in Mv1Lu cells and colorectal adenocarcinoma cells.
    Chen CL; Wu DC; Liu MY; Lin MW; Huang HT; Huang YB; Chen LC; Chen YY; Chen JJ; Yang PH; Kao YC; Chen PY
    J Recept Signal Transduct Res; 2017 Apr; 37(2):189-199. PubMed ID: 27401208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the transforming growth factor-β signaling pathway in the pathogenesis of colorectal cancer.
    Soleimani A; Pashirzad M; Avan A; Ferns GA; Khazaei M; Hassanian SM
    J Cell Biochem; 2019 Jun; 120(6):8899-8907. PubMed ID: 30556274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
    Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
    Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway.
    Yao Y; Zhou Z; Li L; Li J; Huang L; Li J; Qi C; Zheng L; Wang L; Zhang QQ
    Cells; 2019 Jun; 8(6):. PubMed ID: 31242633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development.
    Zeng Q; Phukan S; Xu Y; Sadim M; Rosman DS; Pennison M; Liao J; Yang GY; Huang CC; Valle L; Di Cristofano A; de la Chapelle A; Pasche B
    Cancer Res; 2009 Jan; 69(2):678-86. PubMed ID: 19147584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
    Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
    Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
    Kong J; Du J; Wang Y; Yang M; Gao J; Wei X; Fang W; Zhan J; Zhang H
    Oncotarget; 2016 Nov; 7(46):76224-76237. PubMed ID: 27776350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
    Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
    Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-6--a key regulator of colorectal cancer development.
    Waldner MJ; Foersch S; Neurath MF
    Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK; Schiemann WP
    Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting the Microenvironment in Advanced Colorectal Cancer.
    Tauriello DVF; Batlle E
    Trends Cancer; 2016 Sep; 2(9):495-504. PubMed ID: 28741478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.
    Bu P; Wang L; Chen KY; Rakhilin N; Sun J; Closa A; Tung KL; King S; Kristine Varanko A; Xu Y; Huan Chen J; Zessin AS; Shealy J; Cummings B; Hsu D; Lipkin SM; Moreno V; Gümüş ZH; Shen X
    Nat Commun; 2015 Apr; 6():6879. PubMed ID: 25872451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.
    Halder SK; Beauchamp RD; Datta PK
    Neoplasia; 2005 May; 7(5):509-21. PubMed ID: 15967103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.